Members
| Location: | Vancouver, British Columbia |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.qltinc.com |
| Contact: |
Robert Butchofsky (ir@qltinc.com) 1 604 7077000 |
| Ownership: | Public - NASDAQ: QLTI |
| Description: | QLT is a pharmaceutical company dedicated to the development and commercialization of innovative therapies for the eye. The company's efforts are focused on their commercial product Visudyne® for the treatment of wet-AMD, developing drugs to be delivered in their proprietary punctal plug delivery system, as well as developing their synthetic retinoid program for the treatment of certain orphan inherited retinal diseases. |
| Location: | Vancouver, British Columbia |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.qubiologics.com |
| Contact: |
Hal Gunn (info@qubiologics.com) 1 604 734 1450 |
| Description: | Qu Biologics is a private clinical stage biopharmaceutical company located in Vancouver, B.C., Canada, which has developed Site Specific Immunomodulators (SSIs), a novel class of immunotherapies. SSIs stimulate an innate immune response in targeted organs or tissues to reverse the chronic inflammation underlying many conditions including cancer, inflammatory bowel disease and arthritis. |
